Further studies using (semi-)automated delineations of (3D-)ROIs and including non-radiologic complete responders on DCE-MRI should be conducted to further assess the role of DWI in response evaluation after NST in HER2-positive breast cancer. This evidence concerns the gene ERBB2 and breast cancer.